These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31989414)

  • 1. Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation.
    Yousry C; Zikry PM; Salem HM; Basalious EB; El-Gazayerly ON
    Drug Deliv Transl Res; 2020 Jun; 10(3):801-814. PubMed ID: 31989414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole.
    Basha M; Abd El-Alim SH; Shamma RN; Awad GE
    J Liposome Res; 2013 Sep; 23(3):203-10. PubMed ID: 23607316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.
    Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
    Int J Pharm; 2016 Nov; 513(1-2):688-696. PubMed ID: 27717916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of Highly Deformable Bilosomes for Enhancing the Topical Delivery of Terconazole: In Vitro Characterization, Microbiological Evaluation, and In Vivo Skin Deposition Study.
    Mosallam S; Sheta NM; Elshafeey AH; Abdelbary AA
    AAPS PharmSciTech; 2021 Feb; 22(2):74. PubMed ID: 33586022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-nanoemulsifying System Optimization for Higher Terconazole Solubilization and Non-Irritant Ocular Administration.
    Yousry C; Zikry PM; Basalious EB; El-Gazayerly ON
    Adv Pharm Bull; 2020 Jul; 10(3):389-398. PubMed ID: 32665897
    [No Abstract]   [Full Text] [Related]  

  • 6. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design:
    Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
    Drug Deliv; 2021 Dec; 28(1):77-86. PubMed ID: 33342315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic Polymeric Nanoparticles for Improved Ocular Delivery and Antimycotic Activity of Terconazole.
    Mohsen AM
    J Pharm Sci; 2022 Feb; 111(2):458-468. PubMed ID: 34547306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocubosomal based
    Hosny KM; Rizg WY; Alkhalidi HM; Abualsunun WA; Bakhaidar RB; Almehmady AM; Alghaith AF; Alshehri S; El Sisi AM
    Drug Deliv; 2021 Dec; 28(1):1836-1848. PubMed ID: 34515597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.
    Mosallam S; Ragaie MH; Moftah NH; Elshafeey AH; Abdelbary AA
    Int J Nanomedicine; 2021; 16():119-132. PubMed ID: 33447031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
    Dudhipala N; Ay AA
    Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal targeted Sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies.
    Younes NF; Abdel-Halim SA; Elassasy AI
    Int J Pharm; 2018 Dec; 553(1-2):386-397. PubMed ID: 30393167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
    Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY
    Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
    Girgis GNS
    Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A stepwise optimization strategy to formulate
    Elmotasem H; Awad GEA
    Asian J Pharm Sci; 2020 Sep; 15(5):617-636. PubMed ID: 33193864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
    Elsherif NI; Shamma RN; Abdelbary G
    AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management.
    Ahmed S; Amin MM; El-Korany SM; Sayed S
    Drug Deliv; 2022 Dec; 29(1):2945-2958. PubMed ID: 36073061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.